Artivion, Inc. revenue by segment AORT

Annual Quarterly

Artivion, Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was North America at $62.3 million, 50% of the total. By sales mix, the largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Aortic Stent Grafts at $46.4 million, 37% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024	Q3 FY2024 Sep 30, 2024
Revenue	471	126	116	116	113	113	99	97	96
Operating segments
North America	237 +16.5% share 50.4%	62 +8.3% share 49.6%	59 +22.8% share 50.5%	—	58 +18.8% share 51.4%	58 share 51.0%	48 share 48.3%	49 share 50.6%	49 share 51.3%
Europe The Middle East And Africa Segments	164 +17.6% share 34.8%	45 +15.1% share 35.4%	44 +18.7% share 37.8%	39 +18.1% share 34.0%	36 +19.1% share 31.9%	39 share 34.3%	37 share 37.4%	33 share 34.3%	30 share 31.8%
Asia Pacific	46 +16.5% share 9.7%	12 +9.3% share 9.7%	9 +5.8% share 7.5%	13 +32.3% share 10.9%	12 +18.0% share 10.8%	11 share 9.9%	8 share 8.3%	10 share 9.8%	10 share 10.8%
Latin America	24 +7.4% share 5.1%	7 +20.7% share 5.3%	5 -16.2% share 4.3%	6 +14.9% share 5.1%	7 +12.0% share 5.8%	6 share 4.9%	6 share 6.0%	5 share 5.3%	6 share 6.2%
Sales mix
Aortic Stent Grafts	174 +28.5% share 36.9%	46 +16.5% share 36.9%	44 +21.3% share 38.2%	43 +43.8% share 37.4%	40 +38.2% share 34.9%	40 share 35.3%	37 share 37.0%	30 share 31.0%	29 share 29.9%
On X	111 +22.3% share 23.6%	31 +19.3% share 24.3%	26 +20.3% share 22.3%	28 share 24.0%	27 +24.8% share 23.6%	26 share 22.6%	22 share 21.8%	—	21 share 22.4%
Preservation Services	101 +8.2% share 21.3%	26 +1.3% share 20.6%	25 +23.4% share 21.4%	24 +6.3% share 20.8%	26 +4.8% share 22.7%	26 share 22.6%	20 share 20.4%	23 share 23.3%	25 share 25.6%
Surgical Sealants	77 +2.0% share 16.4%	19 -0.0% share 15.3%	19 +3.9% share 16.2%	20 +1.9% share 17.5%	19 +2.5% share 16.7%	19 share 17.1%	18 share 18.3%	20 share 20.5%	18 share 19.2%
Other Products	9 -14.6% share 1.9%	4 +34.8% share 2.9%	2 -9.0% share 2.0%	0 -80.7% share 0.4%	2 -11.0% share 2.1%	3 share 2.4%	3 share 2.5%	2 share 2.5%	3 share 2.8%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: AORT (NYSE)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Kennesaw, GA
SEC filer status: Large accelerated filer
SEC CIK: 784199
Former names: CRYOLIFE INC (until Jan 6, 2022)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.